EP 1301476 A1 20030416 - NEW COMBINATION OF SEROTONIN AGONIST (5HT2) AND ANTAGONIST (5HT6)AS PHARMACEUTICAL FORMULATION
Title (en)
NEW COMBINATION OF SEROTONIN AGONIST (5HT2) AND ANTAGONIST (5HT6)AS PHARMACEUTICAL FORMULATION
Title (de)
NEUE KOMBINATION EINES SEROTONIN AGONISTEN (5HT2) UND ANTAGONISTEN (5HT6) ALS ARZNEIMITTELZUBEREITUNG
Title (fr)
NOUVELLE ASSOCIATION D'UN AGONISTE DE SEROTONINE (5HT2) ET D'UN ANTAGONISTE DE SEROTONINE (5HT6) SE PRESENTANT SOUS FORME DE FORMULE PHARMACEUTIQUE
Publication
Application
Priority
- SE 0101651 W 20010719
- SE 0002754 A 20000721
Abstract (en)
[origin: WO0208178A1] The invention relates to a method of preventing or treating a disease related to the 5-HT2C receptor and the 5-HT6 receptor, comprising administering to a human or animal subject in need thereof a 5-HT2C receptor agonist and a 5-HT6 receptor antagonist in sufficient amounts to provide a therapeutic affect. The invention also relates to a pharmaceutical composition comprising an effective amount of a combination of a 5-HT2C receptor agonist and a 5-HT6 receptor antagonist, and optionally a pharmaceutically acceptable carrier.
IPC 1-7
IPC 8 full level
C07D 487/04 (2006.01); A61K 31/18 (2006.01); A61K 31/404 (2006.01); A61K 31/496 (2006.01); A61K 31/497 (2006.01); A61K 31/55 (2006.01); A61K 45/00 (2006.01); A61K 45/06 (2006.01); A61P 3/00 (2006.01); A61P 3/04 (2006.01); A61P 13/02 (2006.01); A61P 25/00 (2006.01); A61P 27/06 (2006.01); A61P 43/00 (2006.01); C07D 209/08 (2006.01); C07D 401/14 (2006.01)
CPC (source: EP KR)
A61K 31/18 (2013.01 - EP); A61K 31/404 (2013.01 - EP); A61K 31/497 (2013.01 - EP); A61K 31/55 (2013.01 - EP KR); A61K 45/06 (2013.01 - EP); A61P 3/00 (2017.12 - EP); A61P 3/04 (2017.12 - EP); A61P 13/02 (2017.12 - EP); A61P 25/00 (2017.12 - EP); A61P 27/06 (2017.12 - EP); A61P 43/00 (2017.12 - EP)
C-Set (source: EP)
Citation (search report)
See references of WO 0208178A1
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
DOCDB simple family (publication)
WO 0208178 A1 20020131; AU 2001282734 B2 20061012; AU 8273401 A 20020205; BR 0112661 A 20030624; CA 2411192 A1 20020131; CN 1221254 C 20051005; CN 1443162 A 20030917; EA 006604 B1 20060224; EA 200300183 A1 20030828; EP 1301476 A1 20030416; HK 1057536 A1 20040408; HU P0301346 A2 20030828; HU P0301346 A3 20050530; IL 154057 A0 20030731; JP 2004504376 A 20040212; KR 100845450 B1 20080710; KR 20030036599 A 20030509; MX PA03000548 A 20040405; NO 20030304 D0 20030120; NO 20030304 L 20030312; NZ 523216 A 20050527; PL 360309 A1 20040906; SE 0002754 D0 20000721; YU 2603 A 20060525; ZA 200210234 B 20040318
DOCDB simple family (application)
SE 0101651 W 20010719; AU 2001282734 A 20010719; AU 8273401 A 20010719; BR 0112661 A 20010719; CA 2411192 A 20010719; CN 01813154 A 20010719; EA 200300183 A 20010719; EP 01961472 A 20010719; HK 04100306 A 20040115; HU P0301346 A 20010719; IL 15405701 A 20010719; JP 2002514087 A 20010719; KR 20037000321 A 20030109; MX PA03000548 A 20010719; NO 20030304 A 20030120; NZ 52321601 A 20010719; PL 36030901 A 20010719; SE 0002754 A 20000721; YU P2603 A 20010719; ZA 200210234 A 20021218